HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.

Παρόμοια τεκμήρια

• HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
  ανά: Wirtz, P, κ.ά.
  Έκδοση: (2005)
• Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
  ανά: Lang, B, κ.ά.
  Έκδοση: (2003)
• Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
  ανά: Maddison, P, κ.ά.
  Έκδοση: (2001)
• Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome
  ανά: Titulaer, M, κ.ά.
  Έκδοση: (2010)
• Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
  ανά: Titulaer, M, κ.ά.
  Έκδοση: (2011)